Analytical use of cookies
CVE-2025-62575: biodose\/nmis vulnerability
CVE-2025-62575: high vulnerability affecting biodose\/nmis. Check CVSS, KEV status, business impact and recommended administrator actions.
- CVSS
- 8.7 HIGH
- EPSS
- 30.14%
- Known exploited
- not in KEV
- Product
- biodose\/nmis
What is known
NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.
Business impact
Successful exploitation of CVE-2025-62575, a high vulnerability (CVSS 8.7) affecting biodose\/nmis, may affect the confidentiality, integrity or availability of the vulnerable environment. The exact impact depends on the installed version, exposed interfaces and deployment configuration.
Recommended administrator action
Confirm whether biodose\/nmis is present and compare installed versions with the vendor advisory and NVD record. Apply the vendor patch or documented mitigation; until remediation is complete, reduce exposure of affected interfaces, review relevant logs and monitor for indicators of exploitation. DataHouse can support version verification, managed patching, network exposure reduction, log review and backup validation for dedicated, cloud and colocated environments.